↓ Skip to main content

A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia

Overview of attention for article published in Neuropsychopharmacology, November 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

patent
30 patents
guideline
2 clinical guideline sources

Readers on

mendeley
170 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia
Published in
Neuropsychopharmacology, November 2008
DOI 10.1038/npp.2008.200
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 170 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Netherlands 1 <1%
Spain 1 <1%
Canada 1 <1%
Unknown 167 98%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 26 15%
Student > Ph. D. Student 24 14%
Other 23 14%
Student > Bachelor 17 10%
Student > Master 14 8%
Other 38 22%
Unknown 28 16%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 52 31%
Psychology 31 18%
Neuroscience 13 8%
Agricultural and Biological Sciences 10 6%
Pharmacology, Toxicology and Pharmaceutical Science 10 6%
Other 20 12%
Unknown 34 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 July 2024.
All research outputs
#4,142,306
of 27,145,244 outputs
Outputs from Neuropsychopharmacology
#2,053
of 5,388 outputs
Outputs of similar age
#13,383
of 106,923 outputs
Outputs of similar age from Neuropsychopharmacology
#6
of 34 outputs
Altmetric has tracked 27,145,244 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,388 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.9. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 106,923 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.